Effects of Sodium Bicarbonate on Endurance Performance
SBEP
1 other identifier
interventional
19
1 country
1
Brief Summary
This study is investigating whether taking sodium bicarbonate, a common supplement used by endurance athletes, can improve cycling performance during prolonged exercise and in a time trial. Sodium bicarbonate may help reduce muscle acidity, which could delay fatigue and improve performance. The goal of this study is to determine if this supplement can help athletes perform better during long, intense efforts like those seen in real competitions. Participants in this study are well-trained cyclists who will complete two exercise trials in a laboratory setting. Each trial involves three hours of moderate cycling followed by a 20-30-minute time trial at maximum effort. Before each trial, participants will take either sodium bicarbonate or a placebo. The study will measure performance outcomes, such as time trial results, as well as physiological responses, including heart rate, oxygen use, and muscle fatigue. Researchers hope to better understand how sodium bicarbonate can help endurance athletes and provide guidelines for its use in competitive sports.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Sep 2025
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2025
CompletedFirst Posted
Study publicly available on registry
September 12, 2025
CompletedStudy Start
First participant enrolled
September 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2025
CompletedMarch 30, 2026
March 1, 2026
3 months
July 25, 2025
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Endurance performance
Difference in time trial performance (average power in watts) between placebo and verum condition
20-30 minutes, immediately after completion of the time trial for each condition (Placebo and Verum), assessed on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).
Secondary Outcomes (16)
Difference in questionnaire score - gastrointestinal symptoms
6.5 hours (rest, breakfast, every 30min during 3-hour low-intensity, after TT) for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).
Difference in questionnaire score - Energy & Confidence
3 hours (every 30min during 3-hour low-intensity) for each condition (Placebo and Verum), assessed on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).
Difference in questionnaire score - rate of perceived exertion
3.5 hours (every 30min during 3-hour low-intensity, after TT) for each condition (Placebo and Verum), assessed on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).
Difference in blood count
6.5 hours (rest, every 30min during 3-hour low-intensity, after TT) for each condition (Placebo and Verum), assessed on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).
Difference in pH & HCO3 kinetics
6.5 hours (rest, breakfast, every 30min during 3-hour low-intensity, after TT) for each condition (Placebo and Verum), on test day 1 and test day 2 respectively, with a washout period of 3-7 days between appointments (test days).
- +11 more secondary outcomes
Study Arms (2)
Placebo then Verum
OTHERPlacebo then Verum 3 hour low-intensity ride followed by a 16 km time trial for both conditions. Supplementation of Placebo or Verum before the exercise start.
Verum then Placebo
OTHERVerum then Placebo 3 hour low-intensity ride followed by a 16 km time trial for both conditions. Supplementation of Placebo or Verum before the exercise start.
Interventions
Intake of 0.3 g/kg bodyweight of maltodextrin with hydrogel as placebo and 0.3 g/kg bodyweight of sodium bicarbonate with hydrogel as Verum
Intake of 0.3 g/kg bodyweight of maltodextrin with hydrogel as placebo and 0.3 g/kg bodyweight of sodium bicarbonate with hydrogel as Verum
Eligibility Criteria
You may qualify if:
- age 16-50 years
- well-trained cyclists
- Proof of physical fitness (e.g. sports medical examination required) for measurements with higher intensities (e.g. endurance tests, competition simulation)
- \>10h endurance training per week
You may not qualify if:
- Systemic disease or other known pathology in the organs: heart, lungs, kidney, stomach, spleen, liver, gall bladder, and intestines.
- Evidence of pulmonary disease: forced expiratory volume in one second/forced expiratory volume \< 70% with/without symptoms (cough, sputum) or other evidence of pulmonologic disease.
- Diabetes II.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Salzburglead
- Red Bull Athlete Performance Centercollaborator
Study Sites (1)
Red Bull Athlete Performance Center
Thalgau, Salzburg, 5303, Austria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Researcher
Study Record Dates
First Submitted
July 25, 2025
First Posted
September 12, 2025
Study Start
September 15, 2025
Primary Completion
December 12, 2025
Study Completion
December 12, 2025
Last Updated
March 30, 2026
Record last verified: 2026-03